title: Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma: a diagnostic and therapeutic challenge.
authors.affiliation: Departments of DermatologyPathology, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Oncology, Cairo University, Cairo, Egypt.
authors.forename: Ahmad
authors.initials: A
authors.lastname: Nofal
authors.forename: M Yousry
authors.initials: MY
authors.lastname: Abdel-Mawla
authors.forename: Magda
authors.initials: M
authors.lastname: Assaf
authors.forename: Eman
authors.initials: E
authors.lastname: Salah
authors.forename: Hamdy
authors.initials: H
authors.lastname: Abd-Elazim
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004817:Epidermis / Q000473:pathology; D006801:Humans; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide